/PRNewswire/ A study published in this month s issue of the National Kidney Foundation American Journal of Kidney Diseases (AJKD) provides new insights into.
Study provides real-world assurance that SGLT2 inhibitors have no added risk of fracture in patients with mainly mild kidney disease after a year of use. But follow-up was short, say experts.